FDA Approved: DEXTENZA — Supplemental Application (Ocular Therapeutix, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DEXTENZA (dexamethasone) submitted by Ocular Therapeutix, Inc., related to its labeling for ocular inflammation and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Pain

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

SUPPL AP for DEXTENZA (DEXAMETHASONE)